You've just added:

Checkout Go to Cart
Home / News

News + Media

February 28, 2026

My son was lost to a rare disease 17 years ago. Now the outlook for patients is so much brighter.

Op-Ed Authored by Lord (David) Cameron, former UK Prime Minister and Chair of the OHC Advisory Council published in The Daily Telegraph on Saturday, Feb. 28, 2026 (Rare Disease Day) Rare diseases are not actually that rare. Collectively they affect 500 million people around the world. Some, such as Huntington’s disease...

Continue Reading

March 15, 2016

Harrington Discovery Institute and The American Society for Clinical Investigation honor Jeffrey M. Friedman, MD, PhD

2016 Harrington Prize for Innovation in Medicines Recognizes Discovery of Leptin and the Leptin-Mediated Pathway Continue Reading

February 29, 2016

Harrington Scholar-Innovator Darren Carpizo Launches Z53 Therapeutics, a New Oncology Start-Up Combating Cancer-Associated Mutation

Formed by BioMotiv and Rutgers UniversityCLEVELAND AND NEW BRUNSWICK— FEBRUARY 29, 2016— BioMotiv, a drug development accelerator associated with The Harrington Project, and Rutgers, the State University of New Jersey, are announcing the formation of a new biotechnology startup, Z53 Therapeutics. Z53 Therapeutics aims to... Continue Reading

February 11, 2016

Cleveland Jewish News Profiles 'Genius' Dr. Jonathan Stamler, Harrington Discovery Institute Director

Dr. Jonathan Stamler, director of The Harrington Discovery Institute at University Hospitals in Cleveland, has earned a reputation as a “genius.”“Some people are geniuses,” his father‐in‐law Norman Wain said. “Geniuses have a capacity to work.”“He has this sort of infectious personality to want to drive... Continue Reading

January 13, 2016

Announcing our 2016 Harrington Scholar-Innovator Award Recipients

Cleveland, Ohio – The Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio has announced the 2016 recipients of Harrington Scholar-Innovator Awards. The awards support breakthrough work of physician-scientists whose discovery research shows promise of advancing the standard of care.The Harrington... Continue Reading

January 08, 2016

Harrington Distinguished Scholar Announces Company Collaboration with Bristol-Myers Squibb

Cleveland– January 8, 2016 – Dual Therapeutics, LLC (“Dual Therapeutics”) today announced a strategic collaboration with Bristol-Myers Squibb (NYSE: BMY) to advance small molecule compounds for the treatment of cancer and other diseases. Dual Therapeutics’ small-molecule modulators simultaneously block multiple cancer... Continue Reading

May 01, 2015

A Drug that Regenerates Pancreas Cells to Treat Diabetes

- 2015 Harrington Scholar-Innovator Continue Reading

February 10, 2015

Harrington Discovery Institute and the American Society for Clinical Investigation honor National Cancer Institute's researcher Douglas R. Lowy, MD

2015 Harrington Prize for Innovation in Medicine Recognizes Discoveries Leading to the Human Papillomavirus (HPV) Vaccine Continue Reading

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.